Position history for BlackRock, Inc.'s holdings in BRIDGEBIO ONCOLOGY THERAPEUT
BlackRock, Inc. holds 2.1M shares of BBOT (BRIDGEBIO ONCOLOGY THERAPEUT), worth $18.7M as of 2026-Q1. The position was increased (+0.2% shares). BBOT represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$18.7M
Current Shares
2.1M
Total Value Change
-$5M
Total Shares Change
+39,745
Other major holders of BBOT: WELLINGTON MANAGEMENT GROUP LLP, Alphabet Inc., CITADEL ADVISORS LLC
Increased |
| 2.1M |
+0.2% |
| $18.7M |
| 0.0% |
| $9.74 |
28 |
| 2025-Q4 | Increased | 2.1M | +1.8% | $26.1M | 0.0% | $12.37 | 29 |
| 2025-Q3 | New | 2M | - | $23.7M | 0.0% | $11.47 | 40 |